Dupont Pharma

Press Release | November 18, 2025 SHANGHAI, China, Nov. 18, 2025 — DuPont (NYSE: DD) today held a groundbreaking ceremony for...

Abstract Moisture is a critical external factor affecting the powder behaviour. This work focused on the effect of moisture on...

Abstract Traditional extemporaneous compounding methods of solid oral dosage forms required in early-stage studies are laborious, and the drug’s solid...

Abstract Material-sparing tablet development (MSTD) describes an approach to tablet formulation development that uses the active pharmaceutical ingredient's (API) material...

Abstract Poor aqueous solubility and slow dissolution rate of active pharmaceutical ingredients (APIs) are often encountered challenges during oral drug...

Abstract Predicting the tabletability, i.e., the relationship between tensile strength and compaction pressure, of powder mixtures based on that of...

Abstract The present study aims to develop capsules employing hot melt extrusion (HME) and fused deposition modeling (FDM) three-dimensional (3D)...

Abstract 3D printing (3DP) plays a crucial role in accelerating formulation processes and significantly reduces the time needed to transition...

Abstract This study investigated the influence of solvent casting and hot-melt extrusion manufacturing methods on the physical, chemical, and functional...

Abstract This study explores microdynamic flowability as an innovative approach for early active pharmaceutical ingredient (API) characterisation, when compounds are...